MA22176A1 - Procede pour l'obtention des compositions antimalariales - Google Patents

Procede pour l'obtention des compositions antimalariales

Info

Publication number
MA22176A1
MA22176A1 MA22451A MA22451A MA22176A1 MA 22176 A1 MA22176 A1 MA 22176A1 MA 22451 A MA22451 A MA 22451A MA 22451 A MA22451 A MA 22451A MA 22176 A1 MA22176 A1 MA 22176A1
Authority
MA
Morocco
Prior art keywords
employment
compositions
obtaining anti
obtaining
employment compositions
Prior art date
Application number
MA22451A
Other languages
English (en)
Inventor
Wang S
Li G
Shan C
Zhou Y
Liu G
Ning D
Ding D
Original Assignee
Inst Microbiology & Epidemiology Academy Military Medical Sciences Pla
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25742651&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA22176(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Inst Microbiology & Epidemiology Academy Military Medical Sciences Pla, Novartis Ag filed Critical Inst Microbiology & Epidemiology Academy Military Medical Sciences Pla
Publication of MA22176A1 publication Critical patent/MA22176A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
MA22451A 1990-08-08 1991-06-10 Procede pour l'obtention des compositions antimalariales MA22176A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN90106722A CN1058717A (zh) 1990-08-08 1990-08-08 抗疟新药—复方蒿甲醚及其制备方法
CN91102575A CN1085527C (zh) 1990-08-08 1991-04-24 增效复方抗疟药本芴醇的制备方法

Publications (1)

Publication Number Publication Date
MA22176A1 true MA22176A1 (fr) 1991-12-31

Family

ID=25742651

Family Applications (1)

Application Number Title Priority Date Filing Date
MA22451A MA22176A1 (fr) 1990-08-08 1991-06-10 Procede pour l'obtention des compositions antimalariales

Country Status (27)

Country Link
US (1) US5677331A (fr)
EP (1) EP0500823B1 (fr)
JP (1) JP2562857B2 (fr)
KR (1) KR100221689B1 (fr)
CN (2) CN1058717A (fr)
AP (1) AP231A (fr)
AT (1) ATE135209T1 (fr)
AU (1) AU642747B2 (fr)
CA (1) CA2065285C (fr)
DE (2) DE10199038I2 (fr)
DK (1) DK0500823T3 (fr)
EG (1) EG19905A (fr)
ES (1) ES2084168T3 (fr)
FI (1) FI921491A0 (fr)
GR (1) GR3019313T3 (fr)
HK (1) HK1000312A1 (fr)
HU (1) HU227345B1 (fr)
IE (1) IE72095B1 (fr)
IL (1) IL98463A (fr)
LU (1) LU90844I2 (fr)
MA (1) MA22176A1 (fr)
NL (1) NL300048I2 (fr)
NZ (1) NZ238477A (fr)
PT (1) PT97945B (fr)
SA (1) SA91120263B1 (fr)
WO (1) WO1992002217A1 (fr)
ZA (1) ZA914490B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637594A (en) * 1991-04-11 1997-06-10 Ciba Geigy Corporation Antimalarial synergistic compositions containing benflumetol
WO1993015727A1 (fr) * 1992-02-07 1993-08-19 Ciba-Geigy Ag Composition synergiques antipaludiques contenant du benflumetol
WO1995027964A1 (fr) * 1994-04-12 1995-10-19 Qualcomm Incorporated Procede et dispositif de transport de fret au moyen d'un systeme de navigation par satellite
US5657088A (en) * 1995-12-22 1997-08-12 Cirrus Logic, Inc. System and method for extracting caption teletext information from a video signal
US6136847A (en) * 1996-12-02 2000-10-24 Johns Hopkins University Water-soluble trioxanes as potent and safe antimalarial agents
CH692321A5 (de) 1997-11-03 2002-05-15 Mepha Ag Pharmazeutisch wirksame Zusammensetzung, welche eine gegen Malariaparasiten wirksame Substanz enthält.
CO5040050A1 (es) * 1998-06-25 2001-05-29 Novartis Ag Compuestos de 2-amino-1-(9-arilmetilidina-2,7-dicloro-9h- fluoren-4-ilo)-etanoles n-sustituidos, procedimientos para su obtencion y preparados farmaceuticos que los contienen .
IN191696B (fr) * 1999-02-12 2003-12-20 Council Scient Ind Res
WO2001074353A1 (fr) * 2000-03-31 2001-10-11 Council Of Scientific And Industrial Research Formulation synergetique anti-paludique
AU2001295979A1 (en) * 2000-10-20 2002-04-29 Ajinomoto Co., Inc. Medicinal compositions, dose and method for treating malaria
US7842719B2 (en) * 2002-10-31 2010-11-30 Kemin Foods, L.C. Use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis C, bovine viral diarrhea and classical swine fever virus
WO2004075817A2 (fr) * 2003-02-26 2004-09-10 Vrije Universiteit Brussel Composition pharmaceutique pouvant etre mise en suspension
WO2005023304A2 (fr) * 2003-09-04 2005-03-17 Cipla Limited Compositions antipaludeennes et procede associe
US20110206636A1 (en) * 2003-09-16 2011-08-25 Kemin Foods, LLC Use of Endoperoxides for the Treatment of Infections Caused by Flaviviridae, Including Hepatitis C, Bovine Viral Diarrhea and Classical Swine Fever Virus
WO2007017646A2 (fr) * 2005-08-05 2007-02-15 Cipla Limited Composition antimalarienne
WO2007036947A1 (fr) * 2005-09-30 2007-04-05 Ipca Laboratories Limited Composition anti-paludéenne à libération retardée
EP2034986A2 (fr) * 2006-06-26 2009-03-18 Ranbaxy Laboratories Limited Compositions pharmaceutiques pour l'administration orale à des doses élévées d'arteméther et de luméfantrine
CN100463669C (zh) * 2006-08-31 2009-02-25 广州市医药工业研究所 复方蒿甲醚自乳化剂
WO2008098586A1 (fr) * 2007-02-13 2008-08-21 Dafra Pharma N.V. Composition de support pharmaceutique et composition pharmaceutique
CH700941B1 (de) * 2007-12-04 2010-11-15 Mepha Ag Pharmazeutische Zusammensetzung zur Behandlung von Malaria.
FR2926993B1 (fr) * 2008-02-06 2011-03-11 Sanofi Aventis Association entre un sel de bis-thiazolium ou l'un de ses precurseurs et l'artemisinine ou l'un de ses derives pour le traitement du paludisme
WO2010004573A1 (fr) * 2008-07-07 2010-01-14 Ipca Laboratories Limited Composition pharmaceutique synergiste antipaludique
WO2013143823A1 (fr) * 2012-03-30 2013-10-03 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Poudres de composé roulant amélioré pour application sur la surface de matériaux de noyau de gomme à mâcher
CN103251584A (zh) * 2013-05-09 2013-08-21 西安力邦制药有限公司 注射用蒿甲醚/本芴醇复方脂肪乳的制备及其在疟疾治疗中的应用
WO2015140709A1 (fr) * 2014-03-19 2015-09-24 Novartis Ag Formes posologiques pharmaceutiques solides
CA3059327A1 (fr) 2017-04-24 2018-11-01 Novartis Ag Regime therapeutique de 2-amino-l-(2-(4-fluorophenyl)-3-(4-fluorophenylamino) -8,8-dimethyl-5,6-dihydroimidazo[1,2-a] pyrazin-7(8h)-yl)ethanone et leurs combinaisons
CN113599382B (zh) * 2021-08-20 2023-01-03 兰州大学 喹啉类衍生物在制备治疗糖尿病及其并发症药物中的应用
CN116747218B (zh) * 2023-08-21 2023-10-31 山东省中医药研究院 百秋李醇、百秋李醇复合抗疟组合物及制备抗疟原虫药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN85100978A (zh) * 1985-04-01 1986-08-13 中医研究院中药研究所 还原青蒿素的生产工艺
CN85100781B (zh) * 1985-04-01 1988-07-06 广西壮族自治区桂林制药厂 抗疟药物青蒿酯的制备方法
CN87101346A (zh) * 1987-06-09 1988-03-09 山东省中医药研究所 青蒿素提取工艺
DE68906345T2 (de) * 1988-10-07 1993-10-28 Hoechst Ag Antimalariazusammenstellungen, gebrauchmachend von Quinidin, Artemisinin und ihren Derivaten.
CN1029680C (zh) * 1988-11-10 1995-09-06 军事医学科学院微生物流行病研究所 抗疟新药苯芴醇的合成新工艺

Also Published As

Publication number Publication date
CN1085527C (zh) 2002-05-29
CA2065285A1 (fr) 1992-02-09
AU642747B2 (en) 1993-10-28
AU7954991A (en) 1992-03-02
KR100221689B1 (ko) 1999-09-15
DE10199038I1 (de) 2001-11-22
LU90844I2 (fr) 2002-01-24
ES2084168T3 (es) 1996-05-01
NL300048I1 (nl) 2001-10-01
EP0500823B1 (fr) 1996-03-13
ATE135209T1 (de) 1996-03-15
US5677331A (en) 1997-10-14
DK0500823T3 (da) 1996-04-01
HUT61664A (en) 1993-03-01
AP231A (en) 1993-01-31
NL300048I2 (nl) 2002-03-01
DE69117922D1 (de) 1996-04-18
ZA914490B (en) 1992-03-25
EP0500823A1 (fr) 1992-09-02
HK1000312A1 (en) 1998-02-27
AP9100275A0 (en) 1991-07-31
EG19905A (en) 1996-05-31
JP2562857B2 (ja) 1996-12-11
KR920702217A (ko) 1992-09-03
NZ238477A (en) 1992-12-23
WO1992002217A1 (fr) 1992-02-20
IE72095B1 (en) 1997-03-12
SA91120263B1 (ar) 2004-08-31
HU227345B1 (en) 2011-04-28
IL98463A (en) 1995-10-31
FI921491A (fi) 1992-04-03
FI921491A0 (fi) 1992-04-03
IL98463A0 (en) 1992-07-15
CA2065285C (fr) 2000-05-09
DE69117922T2 (de) 1996-09-05
DE10199038I2 (de) 2007-01-04
PT97945B (pt) 1998-11-30
GR3019313T3 (en) 1996-06-30
IE911989A1 (en) 1992-02-12
HU9201528D0 (en) 1992-08-28
PT97945A (pt) 1992-04-30
CN1058717A (zh) 1992-02-19
JPH05501568A (ja) 1993-03-25
CN1065993A (zh) 1992-11-11

Similar Documents

Publication Publication Date Title
MA22176A1 (fr) Procede pour l'obtention des compositions antimalariales
RO84802A (fr) Procede pour l'obtention des (1-aryle-cyclobutyl)alkylamines
MA22668A1 (fr) Procede de preparation d'oxamides .
RO93871A (fr) Procede d'obtention des derives de propargyloxyacetonitryle substitus
MA21273A1 (fr) Procede pour l'obtention de derives d'hydrazine utiles comme antihypertenseurs;
FR2664279B1 (fr) Procede d'obtention de kappa carraghenanes.
PT71710A (fr) Procede pour l'obtention des nouvelles compositions pour amaigrissement
FR2662168B1 (fr) Procede pour l'obtention de polyamides-imides semi-ordonnes.
RO88035A (fr) Procede d'obtention des derives de 28-methylbrasinolide
MA22277A1 (fr) Procede pour l'obtention d'un effet analgesique ameliore
RO76053A (fr) Procede pour l'obtention des aminoalkyl guanidines
FR2673635B1 (fr) Procede pour la preparation d'une composition aerosol.
RO81671A (fr) Procede d'obtention des composes macrolidiques
RO84114A2 (fr) Procede pour l'obtention des polyethylenglycoles
FR2649317B1 (fr) Procede pour l'obtention de produits cosmetiques personnalises
RO93530A2 (fr) Procede d'obtention des antocyanes
RO88701A2 (fr) Procede d'obtention de alpha-l-aspartyl-lphenylalaninate de methyle
RO86738A2 (fr) Procede pour l'obtention des polyesters
RO81362A2 (fr) Procede d'obtention du chlorhydrate de vibramycine
RO85729A2 (fr) Procede d'obtention du benzylate de methyle
RO90402A2 (fr) Procede pour l'obtention de l'hydrazodicarboxamide
RO86576A2 (fr) Procede pour l'obtention des feuilles d'hydroisolation
RO86120A (fr) Procede pour l'obtention d'un condense ureoformaldehydique
RO86282A2 (fr) Procede d'obtention des alkylethersglycols
RO81603A2 (fr) Procede d'obtention des chloralkylamine-s-triazines